Last reviewed · How we verify
Atorvastatin and Irbesartan
Atorvastatin and Irbesartan is a Small molecule drug developed by Clinical Research Management, Inc.. It is currently in Phase 1 development. Also known as: Lipitor, Avapro.
At a glance
| Generic name | Atorvastatin and Irbesartan |
|---|---|
| Also known as | Lipitor, Avapro |
| Sponsor | Clinical Research Management, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension (PHASE4)
- Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia (PHASE4)
- Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA) (PHASE4)
- Renal Denervation in Diabetic Nephropathy (PHASE4)
- Multiple Treatments for Ebola Virus Disease (EVD) (PHASE1, PHASE2)
- Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia (PHASE3)
- A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin (PHASE1)
- Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Atorvastatin and Irbesartan CI brief — competitive landscape report
- Atorvastatin and Irbesartan updates RSS · CI watch RSS
- Clinical Research Management, Inc. portfolio CI
Frequently asked questions about Atorvastatin and Irbesartan
What is Atorvastatin and Irbesartan?
Atorvastatin and Irbesartan is a Small molecule drug developed by Clinical Research Management, Inc..
Who makes Atorvastatin and Irbesartan?
Atorvastatin and Irbesartan is developed by Clinical Research Management, Inc. (see full Clinical Research Management, Inc. pipeline at /company/clinical-research-management-inc).
Is Atorvastatin and Irbesartan also known as anything else?
Atorvastatin and Irbesartan is also known as Lipitor, Avapro.
What development phase is Atorvastatin and Irbesartan in?
Atorvastatin and Irbesartan is in Phase 1.
Related
- Manufacturer: Clinical Research Management, Inc. — full pipeline
- Also known as: Lipitor, Avapro
- Compare: Atorvastatin and Irbesartan vs similar drugs
- Pricing: Atorvastatin and Irbesartan cost, discount & access